Ratio Review: Analyzing LifeStance Health Group Inc (LFST)’s Price-to-Cash and Price-to-Free Cash Flow

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $7.51 in the prior trading day, LifeStance Health Group Inc (NASDAQ: LFST) closed at $7.52, up 0.13%. In other words, the price has increased by $0.13 from its previous closing price. On the day, 0.67 million shares were traded. LFST stock price reached its highest trading level at $7.63 during the session, while it also had its lowest trading level at $7.47.

Ratios:

Our goal is to gain a better understanding of LFST by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 28.08 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 82.18. For the most recent quarter (mrq), Quick Ratio is recorded 1.32 and its Current Ratio is at 1.32. In the meantime, Its Debt-to-Equity ratio is 0.34 whereas as Long-Term Debt/Eq ratio is at 0.30.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on January 03, 2024, initiated with a Underweight rating and assigned the stock a target price of $7.

On May 15, 2023, TD Cowen Downgraded its rating to Market Perform which previously was Outperform and also upped its target price recommendation from $8 to $9.

Morgan Stanley Upgraded its Equal-Weight to Overweight on January 06, 2023, while the target price for the stock was maintained at $8.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 27 ’24 when Bessler Robert bought 75,000 shares for $7.54 per share.

Miller Lisa K sold 10,540 shares of LFST for $78,523 on Nov 13 ’24. The insider now owns 288,994 shares after completing the transaction at $7.45 per share. On Nov 13 ’24, another insider, Miller Lisa K, who serves as the Officer of the company, bought 10,540 shares for $7.45 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LFST now has a Market Capitalization of 2877452800 and an Enterprise Value of 3263410432. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.39 while its Price-to-Book (P/B) ratio in mrq is 2.00. Its current Enterprise Value per Revenue stands at 2.706 whereas that against EBITDA is 129.495.

Stock Price History:

Over the past 52 weeks, LFST has reached a high of $9.20, while it has fallen to a 52-week low of $4.64. The 50-Day Moving Average of the stock is 6.23%, while the 200-Day Moving Average is calculated to be 18.23%.

Shares Statistics:

The stock has traded on average 1.56M shares per day over the past 3-months and 1837200 shares per day over the last 10 days, according to various share statistics. A total of 378.73M shares are outstanding, with a floating share count of 110.92M. Insiders hold about 71.01% of the company’s shares, while institutions hold 33.20% stake in the company. Shares short for LFST as of 1731628800 were 12294248 with a Short Ratio of 7.88, compared to 1728950400 on 13861390. Therefore, it implies a Short% of Shares Outstanding of 12294248 and a Short% of Float of 15.370000000000001.

Most Popular